Zurich Cantonal Bank
RMD icon

Zurich Cantonal Bank’s ResMed RMD Stock Holding History

Zurich Cantonal Bank’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-70,439
Closed -$17M – 3328
2025
Q4 		$17M Buy
+70,439
New +$18M 0.04% 380

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Zurich Cantonal Bank's RMD Position: Q2 2026 in Review

Zurich Cantonal Bank increased its ResMed (RMD) stake by 6% in Q2 2026, buying an estimated $543K and bringing the position to 46,266 shares worth $9.02M. The position accounts for 0.02% of the portfolio, ranked #513.

Zurich Cantonal Bank first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $24.8M in Q3 2025. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Zurich Cantonal Bank held 46,266 shares of ResMed worth $9.02M as of Q2 2026.
  • Zurich Cantonal Bank bought 2,620 ResMed shares in Q2 2026, an estimated $543K.
  • ResMed made up 0.02% of Zurich Cantonal Bank's portfolio in Q2 2026, its #513 holding.
  • Zurich Cantonal Bank first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
  • Zurich Cantonal Bank's ResMed position peaked at $24.8M in Q3 2025.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.